BGU research team praised by Dr. Fauci for detecting early COVID-19 variants
Hertz and his students are part of the SARS-CoV-2 Assessment of Viral Evolution (SAVE) program at the US National Institutes of Health (NIH).
Chief Medical Advisor to the US President Dr. Anthony Fauci praised Ben-Gurion University of the Negev Prof. Tomer Hertz and his research team for their efforts in detecting early variants of the novel coronavirus.
In a letter sent on Sunday, Fauci said he appreciated “the critical contributions [Hertz’s] team has made during the ongoing COVID-19 pandemic.”
“Your research has been incredibly important to the fast-paced pandemic response and has supported public health efforts around the world. You are a leading example for both the infectious disease and broader biomedical research communities, and I am grateful for your unwavering commitment to global public health,” Fauci wrote, and thanked each member of the team.
Hertz responded, “We have been generating monthly rankings of SARS-CoV-2 variants based on predictions of their escape from antibodies for the group for the last eight months. My students and I have been part of the early detection group that analyzes the viral sequence data.”
Hertz and his students are part of the SARS-CoV-2 Assessment of Viral Evolution (SAVE) program at the US National Institutes of Health. The professor recently co-authored a paper that was published in the journal Nature in March that studied the risk of COVID variants on immune protection.